AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,418,194 | -2.7% | 34,600 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,486,356 | +31.7% | 34,600 | +13.1% | 0.00% | +50.0% |
Q1 2023 | $1,887,408 | +144.7% | 30,600 | +206.0% | 0.00% | +100.0% |
Q4 2022 | $771,300 | +197.8% | 10,000 | +47.9% | 0.00% | – |
Q2 2022 | $259,000 | -96.0% | 6,762 | -95.6% | 0.00% | -100.0% |
Q1 2022 | $6,432,000 | +89.2% | 155,392 | +72.7% | 0.01% | +100.0% |
Q4 2021 | $3,400,000 | +134.8% | 90,000 | +104.8% | 0.00% | +200.0% |
Q3 2021 | $1,448,000 | -70.9% | 43,939 | -40.5% | 0.00% | -75.0% |
Q2 2021 | $4,982,000 | +4.7% | 73,849 | -12.1% | 0.00% | -20.0% |
Q1 2021 | $4,757,000 | -73.2% | 84,018 | -61.5% | 0.01% | -68.8% |
Q4 2020 | $17,759,000 | -11.6% | 217,982 | -22.7% | 0.02% | -23.8% |
Q3 2020 | $20,096,000 | -20.3% | 282,042 | -8.0% | 0.02% | -30.0% |
Q2 2020 | $25,219,000 | +2.2% | 306,503 | -26.9% | 0.03% | -23.1% |
Q1 2020 | $24,679,000 | +155.4% | 419,495 | +348.8% | 0.04% | +254.5% |
Q4 2019 | $9,661,000 | +297.9% | 93,463 | -22.1% | 0.01% | +266.7% |
Q3 2019 | $2,428,000 | +171.3% | 119,951 | +245.1% | 0.00% | +200.0% |
Q2 2019 | $895,000 | – | 34,756 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |